Prodrugs for targeted cancer therapy-Reference-Cited by-同舟云学术

Prodrugs for targeted cancer therapy

Published:2019-05-13 Issue:6 Volume:19 Page:483-502
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Souza Carla¹,Pellosi Diogo Silva²,Tedesco Antonio Claudio¹

Affiliation:

1. Center of Nanotechnology and Tissue Engineering, Department of Chemistry, School of Philosophy, Sciences and Letters of Ribeirão Preto- USP, Ribeirão Preto, Brazil

2. Department of Chemistry, Laboratory of Hybrid Materials, Federal University of São Paulo - UNIFESP, Diadema, Brazil

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2019.1615890

Reference162 articles.

1. Calculated treatment

2. Prodrug strategy for cancer cell-specific targeting: A recent overview

3. Strategies in the designing of prodrugs, taking into account the antiviral and anticancer compounds

4. Evolution of targeted therapies in cancer: opportunities and challenges in the clinic

5. A review on the effects of current chemotherapy drugs and natural agents in treating non–small cell lung cancer

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acid-sensitive prodrugs; a promising approach for site-specific and targeted drug release;European Journal of Medicinal Chemistry;2024-10

2. Strategies for the development of stimuli-responsive small molecule prodrugs for cancer treatment;Frontiers in Pharmacology;2024-07-31

3. Chemoradiotherapy and nanomedicine: Drug mechanisms and delivery systems;WIREs Nanomedicine and Nanobiotechnology;2024-07

4. Two-dimensional MXene-based nano-prodrug for synergistic chemo-photothermal therapy on cancer treatment;Materials Today Chemistry;2024-06

5. Selective activation of prodrugs in breast cancer using metabolic glycoengineering and the tetrazine ligation bioorthogonal reaction;Bioorganic Chemistry;2024-06